Vaayu Chest & Sleep Specialty Centre Launches Pulmonary and Cardiac Wellness & Rehabilitation 2.0

IMT News Desk
IMT News Desk
· 2 min read
Vaayu Chest & Sleep Specialty Centre has launched Pulmonary and Cardiac Wellness & Rehabilitation 2.0, an enhanced program offering centre-based, online and home-based rehab to improve breathing, stamina and quality of life after illness or surgery.

Vaayu Chest & Sleep Specialty Centre has announced the launch of Pulmonary and Cardiac Wellness & Rehabilitation 2.0, an enhanced recovery program designed to help patients regain strength, improve breathing and rebuild quality of life after illness, surgery or long-term health conditions.

For many patients, treatment does not end with medication or hospital discharge. People recovering from lung diseases, heart conditions, severe infections, or major surgeries often continue to experience breathlessness, fatigue, and reduced stamina. Structured rehabilitation plays a crucial role in helping patients rebuild strength, restore confidence, and return to normal daily activities.

Vaayu had introduced its Pulmonary Rehabilitation program during the COVID-19 pandemic, when doctors observed that many patients struggled with breathing and endurance even after recovering from the infection. What began as a small initiative has grown into a comprehensive rehabilitation program. Over the past two years, the centre has delivered more than 14,000 rehabilitation sessions, helping hundreds of patients improve breathing capacity, stamina, and overall wellbeing.

At the launch event, Dr. Ravindra Mehta, Director at Vaayu, emphasized the need for patient-centric recovery models. “Our goal is to create flexible rehabilitation models where care can happen at the centre, online or even at home. If scaled effectively, this approach can significantly improve recovery care while keeping it accessible,” he added.

Dr. Sameer, Consultant Pulmonologist at Vaayu, said “Rehabilitation was initially a new concept for many patients. But those who trusted the process experienced remarkable improvements not only in breathing, but also in strength, confidence and overall wellbeing.”

Chief Guest Mrs. Medini Uday Garudachar highlighted the importance of resilience during recovery. “With the right medical guidance, support, and a positive mindset, recovery becomes possible. Rehabilitation programs help people regain confidence and move forward step by step.”

Read Next

‘One Nation, One Emergency Helpline’ Proposal for Stroke Care Gains Momentum at FICCI Meet
News
April 16, 2026

‘One Nation, One Emergency Helpline’ Proposal for Stroke Care Gains Momentum at FICCI Meet

India’s stroke crisis demands urgent action, and the Indian Stroke Association (ISA) is leading the charge with a bold proposal for a unified national helpline. The ISA presented a comprehensive plan to strengthen stroke care delivery at a FICCI-hosted meeting attended by policymakers, healthcare leaders, and clinical experts. The plenary session, “Strengthening Stroke Care Delivery,” […]
Article by: IMT News Desk
Ivory raises fresh capital to strengthen deep tech offerings
News
April 16, 2026

Ivory raises fresh capital to strengthen deep tech offerings

Ivory, a brain health platform focused on early cognitive screening, has raised $1M in fresh funding, onboarding new investors to deepen its product, clinical and IP capabilities. The round saw participation from Draper Associates, a global venture capital firm with a strong focus on biotech and healthtech, along with SAGE Venture Fund, an AIF fund launched […]
Article by: IMT News Desk
Rubicon Research Enters Indian CNS Formulations Market with Strategic Acquisition
News
April 16, 2026

Rubicon Research Enters Indian CNS Formulations Market with Strategic Acquisition

Rubicon Research Limited today announced the acquisition of an 85% equity ownership in Arinna Lifesciences Limited from its current shareholders. With a portfolio of over 60 brands in chronic therapies, Arinna is one of the few domestic formulation companies principally focused on drugs treating conditions of the central nervous system (“CNS”) with more than 4,000 […]
Article by: IMT News Desk
MSN Laboratories Launches ‘SEMABEST, the First Integrated Made-in-India Semaglutide
News
April 16, 2026

MSN Laboratories Launches ‘SEMABEST, the First Integrated Made-in-India Semaglutide

MSN Laboratories has launched SEMABEST, its semaglutide brand, in the Indian market following approval from the Central Drugs Standard Control Organisation (CDSCO). SEMABEST is priced at nearly 50% lower than the innovator drug, significantly improving affordability and patient access. The therapy is available as a pre-filled pen for subcutaneous administration. In this evolving landscape, SEMABEST […]
Article by: IMT News Desk